These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2278 related articles for article (PubMed ID: 20381654)

  • 41. Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study.
    Haeck JD; Kuijt WJ; Koch KT; Bilodeau L; Henriques JP; Rohling WJ; Baan J; Vis MM; Nijveldt R; van Geloven N; Groenink M; Piek JJ; Tijssen JG; Krucoff MW; De Winter RJ
    Heart; 2010 Feb; 96(3):190-5. PubMed ID: 19858136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
    Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
    Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G
    Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction.
    Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C
    Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.
    Valente S; Lazzeri C; Chiostri M; Giglioli C; Sori A; Tigli S; Gensini GF
    Int J Cardiol; 2009 Feb; 132(1):84-9. PubMed ID: 18207587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
    Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
    Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
    Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration.
    Ballotta A; Ranucci M; Kunkl A; El Baghdady H; Bossone E; Castelvecchio S; Frigiola A; Menicanti L; Di Donato M; Mehta RH
    Am J Cardiol; 2010 Mar; 105(5):640-4. PubMed ID: 20185010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.
    Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV;
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relation of cardiac troponin I measurements at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction.
    Hallén J; Buser P; Schwitter J; Petzelbauer P; Geudelin B; Fagerland MW; Jaffe AS; Atar D
    Am J Cardiol; 2009 Dec; 104(11):1472-7. PubMed ID: 19932777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction.
    Giallauria F; Lucci R; De Lorenzo A; D'Agostino M; Del Forno D; Vigorito C
    Age Ageing; 2006 Nov; 35(6):601-7. PubMed ID: 16951263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-terminal pro-brain natriuretic peptide and tombstoning ST-segment elevation in patients with anterior wall acute myocardial infarction.
    Tomcsányi J; Marosi A; Bózsik B; Somlói M; Zsoldos A; Vecsey T; Arabadzisz H; Nagy E
    Am J Cardiol; 2005 Nov; 96(9):1197-9. PubMed ID: 16253581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 114.